Pre-made Simlukafusp benchmark antibody ( Whole mAb Fusion, anti-FAP therapeutic antibody, Anti-FAPA/SIMP/DPPIV/FAPalpha Antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Simlukafusp biosimilar, Whole mAb Fusion, Anti-FAP Antibody: Anti-FAPA/SIMP/DPPIV/FAPalpha therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-521-1mg	1mg	Inquiry
GMP-Bios-ab-521-10mg	10mg	Inquiry
GMP-Bios-ab-521-100mg	100mg	Inquiry
GMP-Bios-ab-521-xmg	＞100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Simlukafusp biosimilar, Whole mAb Fusion, Anti-FAP Antibody: Anti-FAPA/SIMP/DPPIV/FAPalpha therapeutic antibody
INN Name	Simlukafusp
Target	FAP
Format	Whole mAb Fusion
Derivation
Species Reactivity	Human
CH1 Isotype	IgG1
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Phase-II
Est. Status	Active
100% SI Structure	None
99% SI Structure	None
95-98% SI Structure	None
Year Proposed	2019
Year Recommended	2020
Companies	Roche
Conditions Approved	na
Conditions Active	Malignant melanoma;Renal cell carcinoma
Conditions Discontinued	Solid tumours
Development Tech	na